Publications by authors named "Umut Elboga"

Claim this Profile
G
Ga-PSMA-11 in Staging of Unfavorable Intermediate- and High-Risk Prostate Cancer Reduces Indication for Noncurative Prostatectomy: A Prospective, Multicenter, IAEA Study.
Juliano J Cerci, Stefano Fanti, Enrique E Lobato, Rakesh Kumar, Jolanta Kunikowska, Umut Elboga

J Nucl Med· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Istanbul PSMA PET/CT criteria (IPPC): an imaging-based approach to patient selection for active surveillance.
Levent Kabasakal, Kaan Akçay, Alan Nalan Selçuk, Gamze Beydağı, Elife Akgün

Eur J Nucl Med Mol Imaging· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing outcomes in mCRPC: the impact of androgen receptor inhibitor sequencing before 177Lu-PSMA-617 therapy.
Satı Coşkun Yazgan, Kamil Kayaş, Çağatay Arslan, Caner Kapar, Şura Öztekin

Oncologist· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Adrenal Metastases in Prostate Cancer Patients with [68GA]GA-PSMA PET/CT Imaging.
Ebuzer Kalender, Edanur Ekinci, Umut Elboğa, Ertan Şahin

Curr Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Lu-PSMA-617 Therapy in mCRPC Patients with Liver Metastases: Insights into Survival Outcomes and Predictors of Response.
Ebuzer Kalender, Edanur Ekinci, Umut Elboğa, Ertan Şahin

Biomedicines· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lu-PSMA-617 Radioligand Treatment in Elderly Patients with Metastatic Castration-resistant Prostate Cancer: Therapeutic Efficacy and Safety Assessment.
Ertan Sahin, Umut Elboga, Ufuk Cimen, Merve Okuyan, Yusuf Burak Cayirli

Curr Radiopharm· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of  Ga-FAPI PET/CT in patients with bone metastases in various cancers.
Hacı Arak, Umut Elboga, Yusuf Burak Cayirli, Aydın Aytekin

Ann Nucl Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the relationship between FDG-PET hypometabolism and retinal layer thickness in patients with Alzheimer's disease.
Demet Duman Sastim, Gulcin Elboga, Umut Elboga, Kivanc Gungor

Acta Neurol Belg· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Ga-FAPI PET/CT as an Alternative to F-FDG PET/CT in the Imaging of Invasive Lobular Breast Carcinoma.
Ertan Sahin, Tulay Kus, Alper Aytekin, Evren Uzun, Umut Elboga

J Nucl Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lutetium-177-PSMA-617 radioligand therapy in patients with high volume metastatic prostate cancer prior to chemotherapy and new generation androgen deprivation therapy: Clinical Experience.
Yusuf Zeki Celen, Umut Elboga, Ertan Sahin, Tulay Kus, Merve Okuyan

Hell J Nucl Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Ga-FAPI-04 and F-FDG PET/CT for diagnosis of metastatic lesions in patients with recurrent papillary thyroid carcinoma.
Zeynel Abidin Sayiner, Umut Elboğa, Ertan Sahin, Sadettin Ozturk, Yusuf Burak Cayirli

Hell J Nucl Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lu-PSMA-617 RLT in mCRPC: A single center experience, the earlier could be the better.
Ozlem Nuray Sever, Umut Elboga, Ertan Sahin, Yusuf Burak Cayirli, Havva Yesil Cinkir

Rev Esp Med Nucl Imagen Mol (Engl Ed)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is abnormal metabolism in the olfactory bulb and amygdala associated with bipolar disorder?
Muhammet Sancaktar, Şengül Kocamer Şahin, Bahadır Demir, Umut Elboğa, Gülçin Elboğa

J Neural Transm (Vienna)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Ga-FAPI PET/CT and FDG PET/CT Modalities in Gastrointestinal System Malignancies with Peritoneal Involvement.
Umut Elboga, Ertan Sahin, Tulay Kus, Yusuf Burak Cayirli, Gokmen Aktas

Mol Imaging Biol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic Performance and Clinical Impact of Ga-PSMA-11 PET/CT Imaging in Early Relapsed Prostate Cancer After Radical Therapy: A Prospective Multicenter Study (IAEA-PSMA Study).
Juliano J Cerci, Stefano Fanti, Enrique E Lobato, Jolanta Kunikowska, Omar Alonso, Umut Elboga

J Nucl Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of [68Ga]-FAPI PET/CT and [18F]-FDG PET/CT in Multiple Myeloma: Clinical Experience.
Umut Elboga, Ertan Sahin, Yusuf Burak Cayirli, Merve Okuyan, Gokmen Aktas

Tomography· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is SUVmax a useful marker for progression-free survival in patients with metastatic GEP-NET receiving Lu-DOTATATE therapy?
Fatih Teker, Umut Elboga

Hell J Nucl Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Superiority of Ga-FAPI PET/CT scan in detecting additional lesions compared to FDG PET/CT scan in breast cancer.
Umut Elboga, Ertan Sahin, Tulay Kus, Yusuf Burak Cayirli, Gokmen Aktas

Ann Nucl Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Ga-DOTA-FAPI and FDG PET/CT imaging modalities in the detection of liver metastases in patients with gastrointestinal system cancer.
Ertan Şahin, Umut Elboğa, Yusuf Zeki Çelen, Özlem Nuray Sever, Yusuf Burak Çayırlı

Eur J Radiol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of tumour biomarkers in choosing the appropriate positron emission tomography imaging in follow-up of medullary thyroid cancer.
Ertan Şahin, Umut Elboğa

J Med Imaging Radiat Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of systemic inflammation indexes and FDG PET metabolic parameters on survival in advanced lung adenocarcinoma.
Havva Yesil Cinkir, Umut Elboga

Tumori· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival with transarterial chemoembolization and radioembolization in a patient with cancers of unknown primary.
Gokmen Aktas, Tulay Kus, Taylan Metin, Selim Kervancioglu, Umut Elboga

Onco Targets Ther· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between reticuloendothelial systems' FDG uptake level and clinicopathological features in patient with invasive ductal breast cancer.
Ertan Şahin, Umut Elboğa

Radiol Med· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of nonattenuation-corrected images on FDG-PET/CT in the assessment of solitary pulmonary nodules.
Ertan Şahin, Ahmet Kara, Umut Elboğa

Radiol Med· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lu-177 labelled peptide treatment for radioiodine refractory differentiated thyroid carcinoma.
Umut Elboğa, Mesut Özkaya, Zeynel A Sayiner, Yusuf Zeki Çelen

BMJ Case Rep· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis